DK1392347T3 - Fremgangsmåde til at forhindre celledöd med anvendelse af segmenter af neurale trådproteiner - Google Patents
Fremgangsmåde til at forhindre celledöd med anvendelse af segmenter af neurale trådproteinerInfo
- Publication number
- DK1392347T3 DK1392347T3 DK02729699T DK02729699T DK1392347T3 DK 1392347 T3 DK1392347 T3 DK 1392347T3 DK 02729699 T DK02729699 T DK 02729699T DK 02729699 T DK02729699 T DK 02729699T DK 1392347 T3 DK1392347 T3 DK 1392347T3
- Authority
- DK
- Denmark
- Prior art keywords
- cell death
- proteins
- segments
- preventing cell
- tissue
- Prior art date
Links
- 230000030833 cell death Effects 0.000 title abstract 4
- 230000001537 neural effect Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 230000017074 necrotic cell death Effects 0.000 abstract 3
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29097101P | 2001-05-16 | 2001-05-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1392347T3 true DK1392347T3 (da) | 2005-12-12 |
Family
ID=23118262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02729699T DK1392347T3 (da) | 2001-05-16 | 2002-05-16 | Fremgangsmåde til at forhindre celledöd med anvendelse af segmenter af neurale trådproteiner |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7572450B2 (enExample) |
| EP (1) | EP1392347B1 (enExample) |
| JP (1) | JP2004529179A (enExample) |
| KR (1) | KR20040008177A (enExample) |
| CN (1) | CN1558770A (enExample) |
| AT (2) | ATE381342T1 (enExample) |
| BR (1) | BR0209630A (enExample) |
| CA (1) | CA2446945A1 (enExample) |
| DE (2) | DE60205366T2 (enExample) |
| DK (1) | DK1392347T3 (enExample) |
| ES (1) | ES2247329T3 (enExample) |
| WO (1) | WO2002092115A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7259232B1 (en) * | 2000-10-27 | 2007-08-21 | Nymox Pharmaceutical Corporation | Preferred segments of neural thread protein |
| BR0209990A (pt) * | 2001-05-25 | 2004-06-29 | Nymox Corp | Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células |
| US7317077B2 (en) * | 2001-11-16 | 2008-01-08 | Nymox Pharmaceutical Corporation | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| US7544771B2 (en) * | 2005-02-23 | 2009-06-09 | Nymox Corporation | Protein and its use in diagnosing Alzheimer's disease |
| US20160361380A1 (en) * | 2015-06-12 | 2016-12-15 | Nymox Corporation | Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations |
| US11628202B2 (en) | 2015-07-24 | 2023-04-18 | Nymox Corporation | Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia |
| US10183058B2 (en) | 2016-06-17 | 2019-01-22 | Nymox Corporation | Method of preventing or reducing the progression of prostate cancer |
| US10172910B2 (en) | 2016-07-28 | 2019-01-08 | Nymox Corporation | Method of preventing or reducing the incidence of acute urinary retention |
| US10532081B2 (en) | 2016-09-07 | 2020-01-14 | Nymox Corporation | Method of ameliorating or preventing the worsening or the progression of symptoms of BPH |
| US10335453B2 (en) | 2017-03-01 | 2019-07-02 | Nymox Corporation | Compositions and methods for improving sexual function |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0378924B1 (en) * | 1988-12-21 | 1996-11-13 | The General Hospital Corporation | Detection of neurological disease or dysfunction |
| US5948634A (en) * | 1988-12-21 | 1999-09-07 | The General Hospital Coporation | Neural thread protein gene expression and detection of alzheimer's disease |
| KR100392244B1 (ko) | 1993-04-20 | 2003-11-28 | 더 제너럴 호스피탈 코포레이션 | 신경사단백질유전자발현및알쯔하이머병의검출 |
| CN1300778A (zh) * | 1999-12-22 | 2001-06-27 | 上海博德基因开发有限公司 | 一种新的多肽－人神经元线蛋白15和编码这种多肽的多核苷酸 |
| CN1300779A (zh) | 1999-12-22 | 2001-06-27 | 上海博德基因开发有限公司 | 一种新的多肽－人神经元线蛋白17和编码这种多肽的多核苷酸 |
| US7259232B1 (en) * | 2000-10-27 | 2007-08-21 | Nymox Pharmaceutical Corporation | Preferred segments of neural thread protein |
| DE60222745T2 (de) * | 2001-03-08 | 2008-07-10 | Nymox Pharmaceutical Corp., St. Laurent | Verwendung von neurofilamentproteinen zur behandlung von tumoren |
-
2002
- 2002-05-16 JP JP2002589032A patent/JP2004529179A/ja not_active Ceased
- 2002-05-16 DE DE60205366T patent/DE60205366T2/de not_active Expired - Fee Related
- 2002-05-16 US US10/146,130 patent/US7572450B2/en not_active Expired - Fee Related
- 2002-05-16 DK DK02729699T patent/DK1392347T3/da active
- 2002-05-16 CN CNA02814029XA patent/CN1558770A/zh active Pending
- 2002-05-16 BR BR0209630-7A patent/BR0209630A/pt not_active IP Right Cessation
- 2002-05-16 AT AT05003125T patent/ATE381342T1/de not_active IP Right Cessation
- 2002-05-16 ES ES02729699T patent/ES2247329T3/es not_active Expired - Lifetime
- 2002-05-16 AT AT02729699T patent/ATE300951T1/de not_active IP Right Cessation
- 2002-05-16 WO PCT/CA2002/000712 patent/WO2002092115A2/en not_active Ceased
- 2002-05-16 DE DE60224231T patent/DE60224231D1/de not_active Expired - Lifetime
- 2002-05-16 CA CA002446945A patent/CA2446945A1/en not_active Abandoned
- 2002-05-16 KR KR10-2003-7014850A patent/KR20040008177A/ko not_active Abandoned
- 2002-05-16 EP EP02729699A patent/EP1392347B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004529179A (ja) | 2004-09-24 |
| DE60205366D1 (de) | 2005-09-08 |
| DE60205366T2 (de) | 2006-05-24 |
| KR20040008177A (ko) | 2004-01-28 |
| BR0209630A (pt) | 2004-03-30 |
| ES2247329T3 (es) | 2006-03-01 |
| US20030004107A1 (en) | 2003-01-02 |
| CN1558770A (zh) | 2004-12-29 |
| CA2446945A1 (en) | 2002-11-21 |
| WO2002092115A3 (en) | 2003-05-15 |
| ATE381342T1 (de) | 2008-01-15 |
| ATE300951T1 (de) | 2005-08-15 |
| DE60224231D1 (de) | 2008-01-31 |
| EP1392347B1 (en) | 2005-08-03 |
| WO2002092115A2 (en) | 2002-11-21 |
| HK1060851A1 (en) | 2004-08-27 |
| US7572450B2 (en) | 2009-08-11 |
| EP1392347A2 (en) | 2004-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60021266D1 (de) | Verwendungen von zusammensetzungen zur behandlung oder vermeidung von schlafstörungen mit sehr niedrigdosierten cyclobenzaprine | |
| PL402389A1 (pl) | Sposób hamowania aktywnosci kinazy Raf u ludzi lub zwierzat | |
| DE60143520D1 (de) | Inhibitoren der histon-deacetylase | |
| PT1297851E (pt) | Inibicao de histona-desacetilase como tratamento para hipertrofia cardiaca | |
| BR0304648A (pt) | Combinação de inibidores de ciclooxigenase-2 e talidomida para o tratamento de neoplasia | |
| DE69729007D1 (de) | Hydroxamsäure- und carbonsäure-derivate mit mmp und tnf hemmender wirkung | |
| ATE241358T1 (de) | Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen | |
| DE69925816D1 (de) | Metall chelatoren zur verwendung in der behandlung von alzheimers erkrankung mit clioquinol | |
| DK1075258T3 (da) | Hidtil ukendte fedtsyreanaloger til behandling af adipositas | |
| EA200401341A1 (ru) | Применение остеопротегерина для лечения и/или профилактики фиброзного заболевания | |
| BR0209630A (pt) | Método de impedir morte de célula usando segmentos de proteìnas em cadeia neurais | |
| EP1582105A4 (en) | METHOD FOR PREVENTING THE WATER CONTENT CHANGES OF A COMPOSITION AND ITS USE | |
| ES2101358T3 (es) | Inhibicion de la produccion de tnf. | |
| BR9811099A (pt) | Inibidores de urocinase | |
| ATE554169T1 (de) | Smad7-inhibitoren zur behandlung von krankheiten des zns | |
| DK2009025T3 (da) | Fremgangsmåde til hæmning af osteoklast-aktivitet | |
| NO996555D0 (no) | Fremgangsmåte ved inhibering av nedbrytning fremmet av sulfat- reduserende bakterier | |
| DK0752813T3 (da) | Hæmmere af metozoan-parasit-proteaser | |
| EP0916344A3 (en) | Nef action inhibitor | |
| DK0981549T3 (da) | Anvendelse af inhiberende stof til forbedring af regenereringen af neutroner | |
| ATE251910T1 (de) | Zusammensetzungen zur modulierung der immunantwort und zur behandlung entzündlicher krankheiten | |
| AR026901A1 (es) | Peptidos con n-alquilacion que tienen actividad antiangiogenica | |
| BR0213357A (pt) | Compostos orgânicos | |
| ES2144513T3 (es) | Inhibicion de crecimiento tumoral inducido por traumatismo. | |
| WO2003102148A3 (en) | Human prolactin antagonist-angiogenesis inhibitor fusion proteins |